SNSE (Sensei Biotherapeutics Inc) dropped -9.61 at the last close: Is This Today’s Most Popular Stock?

Sana Meer

Sensei Biotherapeutics Inc (NASDAQ: SNSE) on Friday, plunged -9.61% from the previous trading day, before settling in for the closing price of $10.67. Within the past 52 weeks, SNSE’s price has moved between $5.00 and $18.35.

Healthcare Sector giant saw their annual sales slid by -11.38% over the last five years. The company achieved an average annual earnings per share of 24.29%. With a float of $0.86 million, this company’s outstanding shares have now reached $1.26 million.

Sensei Biotherapeutics Inc (SNSE) Breakdown of a Key Holders of the stock

Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Sensei Biotherapeutics Inc is 32.03%, while institutional ownership is 3.95%. The most recent insider transaction that took place on Dec 09 ’25, was worth 54,575. In this transaction 10% Owner of this company sold 6,612 shares at a rate of $8.25, taking the stock ownership to the 155,142 shares. Before that another transaction happened on Dec 09 ’25, when Company’s 10% Owner sold 3,507 for $7.96, making the entire transaction worth $27,903. This insider now owns 155,142 shares in total.

Sensei Biotherapeutics Inc (SNSE) Recent Fiscal highlights

As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -5.46 earnings per share (EPS) for the period topping the consensus outlook (set at -5.8) by 0.34.

According to the Wall Street analysts, stocks earnings will be around 24.29% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.69% during the next five years compared to -11.38% drop over the previous five years of trading.

Sensei Biotherapeutics Inc (NASDAQ: SNSE) Trading Performance Indicators

Sensei Biotherapeutics Inc (SNSE) is currently performing well based on its current performance indicators. A quick ratio of 7.64 was reported for the most recent quarter.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -21.31, a number that is poised to hit -4.81 in the next quarter and is forecasted to reach -15.05 in one year’s time.

Technical Analysis of Sensei Biotherapeutics Inc (SNSE)

As of the previous 9 days, the stock’s Stochastic %D was 72.92%.

During the past 100 days, Sensei Biotherapeutics Inc’s (SNSE) raw stochastic average was set at 21.86%, which indicates a significant decrease from 50.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.83 in the past 14 days, which was lower than the 1.00 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $9.09, while its 200-day Moving Average is $8.43. Now, the first resistance to watch is $11.13. This is followed by the second major resistance level at $12.61. The third major resistance level sits at $13.77. If the price goes on to break the first support level at $8.49, it is likely to go to the next support level at $7.33. Now, if the price goes above the second support level, the third support stands at $5.85.

Sensei Biotherapeutics Inc (NASDAQ: SNSE) Key Stats

Market capitalization of the company is 12.17 million based on 1,261K outstanding shares. Right now, sales total 0 K and income totals -30,160 K. The company made 0 K in profit during its latest quarter, and -4,570 K in sales during its previous quarter.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.